Source study found
Story checked
Routine newborn screening could catch cytomegalovirus infections before problems appear (opens in a new tab)
medicalxpress.com · 2026-09-27
Short answer
Needs reviewStudy found.
We found the study, but the claim check did not finish.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Routine newborn screening could catch cytomegalovirus infections before problems appear
medicalxpress.com · 2026-09-27
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
We found the study behind this story.
We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.
Open claim evidenceThe source study
Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study
Evidence layer
Claim by claim
The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 5Not checkedA large three-year study suggests that routinely screening all newborns could uncover many congenital cytomegalovirus infections that would otherwise remain hidden.View evidenceHide evidence
As stated48,556 newborns screened; 176 cCMV cases identified
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 2 of 5Not checkedAmong the 176 infants with congenital CMV, 100 babies, or 57%, would not have qualified for targeted screening and might have been missed.View evidenceHide evidence
As stated100 of 176 infants; 57%
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 3 of 5Not checkedAmong the babies who would have been missed without universal screening, eight were later found to have moderate to severe signs of cCMV, three had hearing loss despite appearing otherwise asymptomatic, and 11 ultimately received antiviral treatment.View evidenceHide evidence
As stated8 moderate to severe signs; 3 hearing loss cases; 11 treated
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 4 of 5Not checkedThe researchers used pooled saliva testing with PCR and said this reduced the number of laboratory tests required by 83% compared with testing each sample separately while maintaining high detection sensitivity.View evidenceHide evidence
As stated83% fewer lab tests
Not checked
The source study was found, but this claim couldn't be checked against it.
Claim 5 of 5Not checkedThe article says congenital CMV was not limited to mothers with first infections: among 158 cases with known maternal history, 53% followed a non-primary infection and 47% followed a first infection, with similar rates of significant symptoms, hearing loss and complications at one year.View evidenceHide evidence
As stated53% non-primary; 47% primary
Not checked
The source study was found, but this claim couldn't be checked against it.
Method layer
NewsLink found the paper. Tessa takes you deeper.
NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.
Open the paper in Tessa
Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study
The Lancet Infectious Diseases · 2026
Why this one
Near certain
NewsLink found the paper. Tessa is where you inspect it deeply.
Papers considered
The selected paper, plus nearby candidates.
Crossref, PubMed, Europe PMC · 39 candidate papers
Lessons derived from a 3-year congenital cytomegalovirus screening programme in Israel: a prospective population-based cohort study
The Lancet Infectious Diseases · 2026 · Crossref
Promises and challenges of AI in infectious diseases
The Lancet Infectious Diseases · 2026 · Crossref
The value of infectious disease conferences
The Lancet Infectious Diseases · 2026 · Crossref
Thank you to The Lancet Infectious Diseases statistical and peer reviewers in 2025
The Lancet Infectious Diseases · 2026 · Crossref
Call for letters
The Lancet Infectious Diseases · 2026 · Crossref
Our twenty-five year journey
The Lancet Infectious Diseases · 2026 · Crossref
And 33 more candidates considered.